Genetic factors, such as mutation carriers (amyloid precursor protein, presenilin, and asynuclein) and apolipoprotein E (APOE) ε4 carriers, may be useful in determining the etiology of cognitive impairment [32,33]. The gene discussed is APP; the disease is Cognitive impairment.